Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
Not Applicable (3)
P 2 (2)
P 4 (1)

Trial Status

Not Yet Recruiting5
Recruiting1
Withdrawn1

Clinical Trials (7)

Showing 7 of 7 trials
NCT07652528Not ApplicableNot Yet RecruitingPrimary

CGM-guided Patch Pump vs Basal-Bolus Injection for Steroid-Induced Hyperglycemia in Sudden Sensorineural Hearing Loss: SHIP Trial

NCT07575334Not ApplicableRecruitingPrimary

Acupuncture Therapy for Sudden Sensorineural Hearing Loss

NCT07134075Phase 2Not Yet RecruitingPrimary

Intracochlear Injection of Glucocorticoid

NCT06997406Not ApplicableNot Yet RecruitingPrimary

'Inner Ear Support' Oral Capsule in Patients With Sudden Sensorineural Hearing Loss

NCT06819202Not Yet RecruitingPrimary

Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function

NCT06878599Phase 4Not Yet RecruitingPrimary

Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss

NCT03255473Phase 2WithdrawnPrimary

High Dose Oral Steroids in Sudden Sensorineural Hearing Loss

Showing all 7 trials

Research Network

Activity Timeline